Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 03, 2021

Safety of Natalizumab Reinfusion in MS Patients During Active Sars-Cov2 Infection

Multiple Sclerosis and Related Disorders


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis and Related Disorders
Safety of Natalizumab reinfusion in Multiple Sclerosis patients during active Sars-Cov2 infection
Mult Scler Relat Disord 2021 Oct 24;103345(0)0, D Landi, G Cola, V Mantero, et al

Further Reading